Chopra says Linde/Praxair remedy not enough

The Federal Trade Commission should not have allowed the Linde/Praxair merger to go forward, a Democratic commissioner has said, criticising the proposed remedies and calling for the FTC to look harder at private equity buyers of divested assets.

Get unlimited access to all Global Competition Review content